Answers are grounded in this paper and cite their sources.
Telomerase activity (TA) is crucial for preserving telomeres and preventing senescence, while telomerase inhibition can cause cellular senescence in cancer cells for therapeutic applications. Certain phytochemical substances act as telomerase inhibitors, but understanding their impact on lung and cervical cancer cells is limited. Our study investigated the effects of the natural polyphenol chrysin on A549 and HeLa cell senescence, as well as its interaction with telomerase in vitro and in silico. Chrysin displayed no red blood cell cytotoxicity on or viability changes in WI-38 fibroblasts up to 60 μM. Chrysin decreased TA and cell proliferation at early time points and induced senescence dose-dependently at a later time point in both cell lines. Molecular docking studies demonstrated robust interaction with the telomerase protein TERT, resulting in a Piecewise Linear Potential (PLP) score of −53.79. A density functional theory (DFT) experiment revealed critical insights into molecular characteristics like net charge, orbital geometries (HOMO and LUMO), energy gap (ΔE), and dipole moment. Quantum parameters and ADMET (absorption, distribution, metabolism, elimination, and toxicity) properties of chrysin suggest pharmacological properties and safety. Our findings underscore the intricate interplay between telomerase inhibition, anti-proliferative activity, and senescence, offering valuable insights for future development of novel telomerase-based therapies.
No takes yet. Share an insight, caveat, or question.
Porika et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: